Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease
Daniel Q. Huang(National University of Singapore), Cynthia Behling(Johns Hopkins University), Claude B. Sirlin(University of California San Diego), Harris Siddiqi(University of California San Diego), Suzanne R. Sharpton(University of California San Diego), Jinho Jung(University of California, Irvine), Rohit Loomba(University of California San Diego), Mark A. Valasek(Sharp Memorial Hospital), Ricki Bettencourt(University of California San Diego), Maral Amangurbanova(University of California San Diego), Egbert Madamba(University of California San Diego), Lisa Richards(University of California San Diego), Nobuharu Tamaki(The Japanese Society of Gastroenterological Surgery)
Cited by 46
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k